查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1951855

脫髮症市場分析及預測（至2035年）：按類型、產品類型、服務、技術、應用、最終用戶、設備、流程和解決方案分類

Alopecia Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Application, End User, Device, Process, Solutions
出版日期: | 出版商: Global Insight Services | 英文 351 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

預計到2034年，脫髮症市場規模將從2024年的81億美元成長至139億美元，年複合成長率約為5.2%。脫髮症市場涵蓋各種脫髮症治療方法方案，包括藥品、植髮服務和外用產品。該市場涵蓋多種類型的脫髮症，包括男性型脫髮症和脫髮症。人們對脫髮的認知不斷提高以及脫髮症率的上升是推動市場成長的主要因素。再生醫學和個人化治療的創新是關鍵趨勢，為致力於滿足脫髮患者美觀和心理需求的相關人員提供了廣泛的機會。

脫髮症市場正經歷顯著成長，主要驅動力來自治療方法的進步和消費者意識的提高。其中，製藥領域成長最為迅猛，口服和外用藥物是主要細分市場。這些治療方法因其有效性和易用性而備受關注。生物製藥，尤其是JAK抑制劑，憑藉其標靶定向和良好的治療效果，已成為極具發展潛力的細分市場。醫療設備領域也緊隨其後，雷射治療和微針設備日益普及。這些設備屬於非侵入性治療，因其能夠有效促進頭髮生長而備受青睞。營養補充劑領域，包括維生素和膳食補充劑，也呈現成長勢頭，這主要得益於消費者對整體和自然健康方式的偏好。隨著人們對脫髮症治療方法的認知和接受度不斷提高，預計這些細分市場將持續成長，並為市場參與企業提供盈利的機會。

市場區隔
類型 雄性脫髮症、脫髮症、疤痕性脫髮症、牽引性脫髮症、全脫髮症、普禿、休止期脫髮症、脫髮症脫髮症
產品 外用藥物、口服藥物、注射治療、雷射設備、洗髮精和護髮素、假髮和髮片、營養補充劑和美容精華液
服務 諮商服務、植髮、頭皮微色素沉著、心理輔導與支持
科技 幹細胞療法、富血小板血漿（PRP）療法、低功率雷射療法、基因療法
適用的 皮膚科診所、居家照護、美容院/水療中心、醫院
最終用戶 男人、女人、孩子
裝置 攜帶式、穿戴式式和固定式設備
過程 非手術治療、手術治療
解決方案 預防和修復解決方案

脫髮症市場的特點是治療方法多樣化，其中外用和口服藥物佔據了大部分市場佔有率。近期推出的新產品引進了創新治療方法，拓展了治療選擇，並促進了價格競爭。市場正朝著個人化醫療的方向發展，因此研發投入顯著增加。北美憑藉其完善的醫療基礎設施和較高的消費者意識，繼續引領市場。亞太地區由於脫髮症病例的增加和醫療支出的成長，已成為一個極具潛力的市場。脫髮症市場競爭激烈，主要企業致力於透過策略聯盟和併購來鞏固自身地位。監管對市場影響巨大，產品核可和銷售都有嚴格的規定。歐洲市場尤其受到法規結構的嚴重影響，這直接影響產品的供應和定價。各公司正加大對合規和創新的投入，以應對這些挑戰。技術進步和消費者對有效治療方法的需求正在推動市場發展，使其格局不斷變化。這項全面的分析證實了該市場具有持續成長和創新的潛力。

主要趨勢和促進因素：

脫髮症市場正經歷顯著成長，這主要得益於人們對脫髮症狀的認知不斷提高以及脫髮症狀日益普遍。關鍵趨勢包括對非侵入性治療方法的需求不斷成長，以及針對脫髮症根本原因的新型治療方法的研發。幹細胞療法和富血小板血漿（PRP）療法等再生醫學技術的進步正日益受到關注。這些創新有望提供有效且微創的毛髮再生解決方案。消費者對天然和有機護髮產品的偏好日益成長，也對市場產生了影響。這種轉變正在加速製造商對草藥和植物來源治療方法研發的投資。此外，社群媒體和名人代言的影響力不斷增強，進一步提升了消費者的興趣和認知，從而推動了市場成長。新興市場蘊藏著眾多機遇，這些市場中不斷成長的可支配收入和不斷變化的生活方式正在推動對先進護髮解決方案的需求。此外，遠端醫療和個人化治療方案等數位技術的整合正在提高患者的參與度和治療依從性。能夠利用這些技術的公司將佔據有利地位，從而獲得更大的市場佔有率。對個人化醫療和以患者為中心的理念的重視有望加速創新並擴大市場覆蓋範圍。總體而言，隨著人們意識的提高、技術的進步和消費者偏好的轉變，脫髮症市場預計將持續成長。

目錄

第1章執行摘要

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制
  • 複合年均成長率：成長分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章 細分市場分析

  • 市場規模及預測：依類型
    • 雄性脫髮症
    • 脫髮症
    • 瘢痕性脫髮症
    • 牽引性脫髮症
    • 全脫髮症
    • 脫髮症
    • 休止期脫髮症
    • 生長期脫髮症
  • 市場規模及預測：依產品分類
    • 局部治療
    • 口服藥物
    • 注射治療
    • 雷射設備
    • 洗髮精和護髮素
    • 假髮和髮片
    • 補充
    • 美容精華液
  • 市場規模及預測：依服務分類
    • 諮詢服務
    • 植髮
    • 頭皮微色素沉著
    • 諮詢和支持
  • 市場規模及預測：依技術分類
    • 幹細胞療法
    • 富血小板血漿（PRP）
    • 低功率雷射療法
    • 基因治療
  • 市場規模及預測：依應用領域分類
    • 皮膚科診所
    • 居家照護
    • 美容美髮沙龍和水療中心
    • 醫院
  • 市場規模及預測：依最終用戶分類
    • 男性
    • 女士
    • 兒童
  • 市場規模及預測：依設備分類
    • 行動裝置
    • 穿戴式裝置
    • 固定設備
  • 市場規模及預測：依製程分類
    • 非手術治療方法
    • 手術治療
  • 市場規模及預測：按解決方案分類
    • 預防性解決方案
    • 復原解決方案

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地區
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲地區

第6章 市場策略

  • 需求與供給差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 法規概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 主要企業的策略

第8章 公司簡介

  • Follica
  • Concert Pharmaceuticals
  • Histogen
  • Cassiopea
  • Samumed
  • Aclaris Therapeutics
  • River Town Therapeutics
  • Cellmid
  • Almirall
  • Kintor Pharmaceutical
  • Dermira
  • HCell
  • Histogenics
  • Perrigo
  • Repli Cel Life Sciences
  • Polichem
  • Revolutionary Science
  • Hair Clone
  • Kerastem
  • Stemson Therapeutics

第9章：關於我們

簡介目錄
Product Code: GIS21314

Alopecia Market is anticipated to expand from $8.1 billion in 2024 to $13.9 billion by 2034, growing at a CAGR of approximately 5.2%. The Alopecia Market encompasses treatments and solutions for hair loss disorders, including pharmaceuticals, hair transplant services, and topical products. This market addresses various alopecia types, such as androgenetic alopecia and alopecia areata. Rising awareness and increasing prevalence of hair loss conditions are propelling growth. Innovations in regenerative medicine and personalized therapeutics are key trends, offering promising opportunities for stakeholders aiming to cater to the aesthetic and psychological needs of affected individuals.

The Alopecia Market is experiencing significant growth, primarily driven by advancements in treatment options and increasing awareness. Within this market, the pharmaceuticals segment stands out as the top performer, with oral and topical treatments being the most prominent sub-segments. These treatments are gaining traction due to their effectiveness and ease of use. Biologics, particularly JAK inhibitors, are emerging as a promising sub-segment, showing potential for future growth due to their targeted action and favorable outcomes. The devices segment follows closely, with laser-based therapies and microneedling devices gaining popularity. These devices are appreciated for their non-invasive nature and ability to stimulate hair regrowth effectively. The nutraceuticals segment, encompassing vitamins and supplements, is also gaining momentum, driven by the increasing consumer preference for holistic and natural approaches to health. As awareness and acceptance of alopecia treatments continue to rise, these segments are poised for sustained growth, offering lucrative opportunities for market participants.

Market Segmentation
TypeAndrogenetic Alopecia, Alopecia Areata, Cicatricial Alopecia, Traction Alopecia, Alopecia Totalis, Alopecia Universalis, Telogen Effluvium, Anagen Effluvium
ProductTopical Treatments, Oral Drugs, Injectable Treatments, Laser Devices, Shampoos and Conditioners, Wigs and Hairpieces, Supplements, Serums
ServicesConsultation Services, Hair Transplantation, Scalp Micropigmentation, Counseling and Support
TechnologyStem Cell Therapy, Platelet-Rich Plasma (PRP), Low-Level Laser Therapy, Gene Therapy
ApplicationDermatology Clinics, Homecare, Salons and Spas, Hospitals
End UserMen, Women, Children
DeviceHandheld Devices, Wearable Devices, Stationary Devices
ProcessNon-Surgical, Surgical
SolutionsPreventive Solutions, Restorative Solutions

The Alopecia market is characterized by a diverse array of treatments, with topical and oral solutions dominating market share. Recent product launches have introduced innovative therapies, enhancing treatment options and driving competitive pricing strategies. The market is witnessing a shift toward personalized medicine, with significant investments in research and development. North America remains at the forefront, bolstered by a strong healthcare infrastructure and high consumer awareness. The Asia-Pacific region is emerging as a lucrative market, driven by increasing incidences of alopecia and rising healthcare expenditure. Competition in the Alopecia market is intense, with key players focusing on strategic collaborations and mergers to strengthen their market presence. Regulatory influences are significant, with stringent guidelines governing product approvals and marketing. The European market is particularly shaped by regulatory frameworks, impacting product availability and pricing. Companies are investing in compliance and innovation to navigate these challenges. The landscape is dynamic, with technological advancements and consumer demand for effective treatments driving market evolution. This comprehensive analysis underscores the market's potential for sustained growth and innovation.

Geographical Overview:

The Alopecia market is witnessing varied growth patterns across regions, with distinct emerging opportunities. North America leads due to advanced healthcare infrastructure and increasing awareness of alopecia treatments. The region's robust research and development landscape supports innovative therapies, enhancing market prospects. Europe follows, driven by a growing aging population and rising demand for effective alopecia solutions. The emphasis on dermatological research and personalized medicine contributes to market expansion. In Asia Pacific, burgeoning economies and increasing disposable incomes fuel market growth. Countries like China and India are becoming significant players, with rising investments in healthcare infrastructure. Latin America presents promising opportunities as awareness of alopecia increases, coupled with improving healthcare access. Brazil and Mexico are key contributors to this growth. The Middle East & Africa also show potential, driven by increasing healthcare investments and a growing focus on dermatological conditions. The region's expanding middle class further bolsters market opportunities.

The global alopecia market is intricately influenced by tariffs, geopolitical tensions, and evolving supply chain dynamics. In Japan and South Korea, heightened trade tensions with the US have prompted strategic shifts towards bolstering domestic pharmaceutical capabilities and reducing dependency on imports. China, facing international scrutiny, is investing heavily in biotechnological advancements and fostering homegrown pharmaceutical innovation. Taiwan, while a pivotal player in the pharmaceutical supply chain, is vulnerable to cross-strait tensions, necessitating diversification strategies. The parent market is experiencing robust growth driven by increased prevalence of alopecia and rising consumer awareness. By 2035, the market is expected to expand significantly, contingent on resilient supply chains and strategic alliances. Additionally, Middle East conflicts could exacerbate global supply chain disruptions and elevate energy costs, impacting production and distribution logistics.

Key Trends and Drivers:

The alopecia market is experiencing substantial growth, driven by rising awareness and increasing prevalence of hair loss conditions. Key trends include the growing demand for non-invasive treatment options and the development of novel therapeutics targeting underlying causes of alopecia. Technological advancements in regenerative medicine, such as stem cell therapy and platelet-rich plasma (PRP) treatments, are gaining traction. These innovations promise effective, minimally invasive solutions for hair restoration. The market is also influenced by the expanding consumer preference for natural and organic hair care products. This shift is encouraging manufacturers to invest in research and development of herbal and plant-based treatments. Additionally, the increasing influence of social media and celebrity endorsements is driving consumer interest and awareness, further boosting market growth. Opportunities abound in emerging markets where rising disposable incomes and changing lifestyles are fueling demand for advanced hair care solutions. Furthermore, the integration of digital technologies, such as telemedicine and personalized treatment plans, is enhancing patient engagement and adherence. Companies that can leverage these technologies are well-positioned to capture market share. The focus on personalized medicine and patient-centric approaches is expected to accelerate innovation and expand the market's reach. Overall, the alopecia market is set for continued expansion as awareness, technological advancements, and consumer preferences evolve.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by End User
  • 2.7 Key Market Highlights by Device
  • 2.8 Key Market Highlights by Process
  • 2.9 Key Market Highlights by Solutions

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Androgenetic Alopecia
    • 4.1.2 Alopecia Areata
    • 4.1.3 Cicatricial Alopecia
    • 4.1.4 Traction Alopecia
    • 4.1.5 Alopecia Totalis
    • 4.1.6 Alopecia Universalis
    • 4.1.7 Telogen Effluvium
    • 4.1.8 Anagen Effluvium
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Topical Treatments
    • 4.2.2 Oral Drugs
    • 4.2.3 Injectable Treatments
    • 4.2.4 Laser Devices
    • 4.2.5 Shampoos and Conditioners
    • 4.2.6 Wigs and Hairpieces
    • 4.2.7 Supplements
    • 4.2.8 Serums
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Consultation Services
    • 4.3.2 Hair Transplantation
    • 4.3.3 Scalp Micropigmentation
    • 4.3.4 Counseling and Support
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Stem Cell Therapy
    • 4.4.2 Platelet-Rich Plasma (PRP)
    • 4.4.3 Low-Level Laser Therapy
    • 4.4.4 Gene Therapy
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Dermatology Clinics
    • 4.5.2 Homecare
    • 4.5.3 Salons and Spas
    • 4.5.4 Hospitals
  • 4.6 Market Size & Forecast by End User (2020-2035)
    • 4.6.1 Men
    • 4.6.2 Women
    • 4.6.3 Children
  • 4.7 Market Size & Forecast by Device (2020-2035)
    • 4.7.1 Handheld Devices
    • 4.7.2 Wearable Devices
    • 4.7.3 Stationary Devices
  • 4.8 Market Size & Forecast by Process (2020-2035)
    • 4.8.1 Non-Surgical
    • 4.8.2 Surgical
  • 4.9 Market Size & Forecast by Solutions (2020-2035)
    • 4.9.1 Preventive Solutions
    • 4.9.2 Restorative Solutions

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Application
      • 5.2.1.6 End User
      • 5.2.1.7 Device
      • 5.2.1.8 Process
      • 5.2.1.9 Solutions
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Application
      • 5.2.2.6 End User
      • 5.2.2.7 Device
      • 5.2.2.8 Process
      • 5.2.2.9 Solutions
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Application
      • 5.2.3.6 End User
      • 5.2.3.7 Device
      • 5.2.3.8 Process
      • 5.2.3.9 Solutions
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Application
      • 5.3.1.6 End User
      • 5.3.1.7 Device
      • 5.3.1.8 Process
      • 5.3.1.9 Solutions
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Application
      • 5.3.2.6 End User
      • 5.3.2.7 Device
      • 5.3.2.8 Process
      • 5.3.2.9 Solutions
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Application
      • 5.3.3.6 End User
      • 5.3.3.7 Device
      • 5.3.3.8 Process
      • 5.3.3.9 Solutions
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Application
      • 5.4.1.6 End User
      • 5.4.1.7 Device
      • 5.4.1.8 Process
      • 5.4.1.9 Solutions
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Application
      • 5.4.2.6 End User
      • 5.4.2.7 Device
      • 5.4.2.8 Process
      • 5.4.2.9 Solutions
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Application
      • 5.4.3.6 End User
      • 5.4.3.7 Device
      • 5.4.3.8 Process
      • 5.4.3.9 Solutions
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Application
      • 5.4.4.6 End User
      • 5.4.4.7 Device
      • 5.4.4.8 Process
      • 5.4.4.9 Solutions
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Application
      • 5.4.5.6 End User
      • 5.4.5.7 Device
      • 5.4.5.8 Process
      • 5.4.5.9 Solutions
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Application
      • 5.4.6.6 End User
      • 5.4.6.7 Device
      • 5.4.6.8 Process
      • 5.4.6.9 Solutions
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Application
      • 5.4.7.6 End User
      • 5.4.7.7 Device
      • 5.4.7.8 Process
      • 5.4.7.9 Solutions
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Application
      • 5.5.1.6 End User
      • 5.5.1.7 Device
      • 5.5.1.8 Process
      • 5.5.1.9 Solutions
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Application
      • 5.5.2.6 End User
      • 5.5.2.7 Device
      • 5.5.2.8 Process
      • 5.5.2.9 Solutions
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Application
      • 5.5.3.6 End User
      • 5.5.3.7 Device
      • 5.5.3.8 Process
      • 5.5.3.9 Solutions
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Application
      • 5.5.4.6 End User
      • 5.5.4.7 Device
      • 5.5.4.8 Process
      • 5.5.4.9 Solutions
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Application
      • 5.5.5.6 End User
      • 5.5.5.7 Device
      • 5.5.5.8 Process
      • 5.5.5.9 Solutions
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Application
      • 5.5.6.6 End User
      • 5.5.6.7 Device
      • 5.5.6.8 Process
      • 5.5.6.9 Solutions
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Application
      • 5.6.1.6 End User
      • 5.6.1.7 Device
      • 5.6.1.8 Process
      • 5.6.1.9 Solutions
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Application
      • 5.6.2.6 End User
      • 5.6.2.7 Device
      • 5.6.2.8 Process
      • 5.6.2.9 Solutions
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Application
      • 5.6.3.6 End User
      • 5.6.3.7 Device
      • 5.6.3.8 Process
      • 5.6.3.9 Solutions
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Application
      • 5.6.4.6 End User
      • 5.6.4.7 Device
      • 5.6.4.8 Process
      • 5.6.4.9 Solutions
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Application
      • 5.6.5.6 End User
      • 5.6.5.7 Device
      • 5.6.5.8 Process
      • 5.6.5.9 Solutions

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Follica
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Concert Pharmaceuticals
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Histogen
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Cassiopea
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Samumed
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Aclaris Therapeutics
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 River Town Therapeutics
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Cellmid
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Almirall
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Kintor Pharmaceutical
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Dermira
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 HCell
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Histogenics
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Perrigo
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Repli Cel Life Sciences
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Polichem
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Revolutionary Science
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Hair Clone
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Kerastem
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Stemson Therapeutics
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us